Sage Therapeutics Inc (SAGE)
4.85
-0.06
(-1.22%)
USD |
NASDAQ |
Nov 21, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Profit Margin (Quarterly): -788.1% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -788.1% |
| June 30, 2024 | -1.19K% |
| March 31, 2024 | -1.37K% |
| December 31, 2023 | -41.95% |
| September 30, 2023 | -7.42K% |
| June 30, 2023 | -6.48K% |
| March 31, 2023 | -4.46K% |
| December 31, 2022 | -5.14K% |
| September 30, 2022 | -7.90K% |
| June 30, 2022 | -8.41K% |
| March 31, 2022 | -7.72K% |
| December 31, 2021 | -7.60K% |
| September 30, 2021 | -9.04K% |
| Date | Value |
|---|---|
| June 30, 2021 | -6.53K% |
| March 31, 2021 | -6.05K% |
| December 31, 2020 | 87.89% |
| September 30, 2020 | -6.45K% |
| June 30, 2020 | -12.52K% |
| March 31, 2020 | -5.54K% |
| December 31, 2019 | -8.60K% |
| September 30, 2019 | -5.04K% |
| June 30, 2019 | -19.27K% |
| March 31, 2019 | -35.14K% |
| December 31, 2018 | -58.02K% |
| September 30, 2018 | |
| June 30, 2018 | -18.86% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.52K%
Minimum
Jun 2020
87.89%
Maximum
Dec 2020
-5.66K%
Average
-6.47K%
Median
Profit Margin (Quarterly) Benchmarks
| Outset Medical Inc | -97.47% |
| Biogen Inc | 15.76% |
| Johnson & Johnson | 11.99% |
| Lifecore Biomedical Inc | -65.70% |
| Organon & Co | 22.69% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.20% |
| Return on Assets | -43.07% |
| Return on Invested Capital | -48.20% |
| Gross Profit Margin (Quarterly) | 55.54% |
| Operating Margin (Quarterly) | -852.5% |
| Return on Net Operating Assets | -965.1% |